Display Settings:

Format

Send to:

Choose Destination

    Trends Biochem Sci. 1991 Aug;16(8):305-9.

    Molecular studies on trypanothione reductase, a target for antiparasitic drugs.

    Walsh C, Bradley M, Nadeau K.

    Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115.

    Trypanosoma and Leishmania are parasitic protozoa that cause a variety of diseases, which include African sleeping sickness and oriental sore. Attempts to determine pharmaceutically exploitable differences between host and parasite biochemistry have identified the unique trypanothione pathway as a possible target. This pathway includes the enzyme trypanothione reductase, the parasite analogue of glutathione reductase.

    PMID: 1957352 [PubMed - indexed for MEDLINE]

    Supplemental Content